Francesco Latrofa

Education and professional experience
Fellowship, Postgraduate School of Endocrinology, University of Pisa, Italy, 1993-99
Postgraduate Degree with honors in Endocrinology, School of Endocrinology and Metabolic Disease, University of Pisa, Italy
Post-Doc Researcher, Autoimmune Disease Unit, Cedars-Sinai Research Institute and School of Medicine, University of California, Los Angeles, 2000-2003
Assistant Professor, Department of Endocrinology and Metabolism, University Hospital of Pisa, Italy, 2004-2007 and 2008-2009
Associate Professor, Department of Endocrinology and Metabolism, University Hospital of Pisa, Italy, 2015 to date

Affiliations
The Endocrine Society, European Society of Endocinology, Società Italiana di Endocrinologia, American Thyroid Association, European Thyroid Association, Associazione Italiana della Tiroide

Peer reviewed publications (most recent)
• Viola N et al. Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review. Endocrine. 2022 Nov 17:1-7
• Brancatella A et al. Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockade. Eur Thyroid J. 2022 Jun 29;11(4)
• Brancatella A et al. Subacute Thyroiditis During the SARS-CoV-2 Pandemic. J Endocr Soc. 2021 Jul 28;5(10. eCollection 2021 Oct 1
• Brancatella A et al, Management of Thyrotoxicosis Induced by PD1 or PD-L1 Blockade. J Endocr Soc. 2021 May 15;5(9). eCollection 2021 Sep 1
• Rotondo Dottore G et al. Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis. Eur Thyroid J. 2021 Jun;10(3):237-247
• Rotondi M et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021 May;44(5):1085-1090
• Brancatella A et al. Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series. J Clin Endocrinol Metab. 2020 Oct 1;105(10)
• Rotondi M et al. Patients with chronic autoimmune thyroiditis are not at higher risk for developing clinically overt thyroid cancer: a 10-year follow-up study. Eur J Endocrinol. 2020 Sep;183(3):317-323
• Lanzolla G et al. Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves' Disease: results of a pilot study. J Endocrinol Invest. 2020 Dec;43(12):1759-1768
• Matrone A et al. Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with Radioiodine. J Clin Endocrinol Metab. 2020 Aug 1;105(8)
• Brancatella A et al. Subacute Thyroiditis After Sars-COV-2 Infection. J Clin Endocrinol Metab. 2020 Jul 1;105(7)
• Croce L et al. Compared with classic Hashimoto's thyroiditis, chronic autoimmune serum-negative thyroiditis requires a lower substitution dose of L-thyroxine to correct hypothyroidism. J Endocrinol Invest. 2020 Nov; 43(11)1631-1636
• Lupi I et al. Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism. J Clin Endocrinol Metab. 2020 May 1;105(5): dgaa092
• Ricci D et al.The Detection of Serum IgMs to Thyroglobulin in Subacute Thyroiditis Suggests a Protective Role of IgMs in Thyroid Autoimmunity. J Clin Endocrinol Metab. 2020 Jun 1;105(6)
• Matrone A et al. The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy. Front Oncol. 2019 Dec 17;9:1390
• Marinò M et al. Orbital diseases mimicking graves' orbitopathy: a long-standing challenge in differential diagnosis.J Endocrinol Invest. 2020 Apr;43(4):401-411
• Lupi I et al. Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases. Endocrinol Diabetes Metab Case Rep. 2019 Oct 12;2019:19-0102
• Brancatella A et al. Graves' Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature. Eur Thyroid J. 2019 Jul;8(4):192-195